Abstract
The safety of statins treatment in hypercholesterolemic patients (around 50 million in USA) is very well documented. However, these works indicate that about 10% of patients develop adverse effects in skeletal muscle and other tissues. The mechanisms of statins toxicity seems to be related to cell death mediated by mitochondrial dysfunction associated with alterations in calcium homeostas…